111 Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
111 Capital's AMGN Position: Q2 2026 in Review
111 Capital reduced its Amgen (AMGN) stake by 46% in Q2 2026, selling an estimated $1.12M and leaving 3,851 shares worth $1.39M. The position accounts for 0.24% of the portfolio, ranked #93.
111 Capital first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.5M in Q1 2026. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- 111 Capital held 3,851 shares of Amgen worth $1.39M as of Q2 2026.
- 111 Capital sold 3,259 Amgen shares in Q2 2026, an estimated $1.12M.
- Amgen made up 0.24% of 111 Capital's portfolio in Q2 2026, its #93 holding.
- 111 Capital first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- 111 Capital's Amgen position peaked at $2.5M in Q1 2026.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.